Your Location：
Home >
Browse articles >
Tumor targeting of 125I-labeled anti-EGFR monoclonal antibody LA22 in HT-29 human colon cancer
RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE | Updated：2021-01-29
Tumor targeting of 125I-labeled anti-EGFR monoclonal antibody LA22 in HT-29 human colon cancer
- Nuclear Science and Techniques Vol.21, Issue 2, (2010)
- DOI：10.13538/j.1001-8042/nst.21.84-88
Published：20 April 2010，
Received：12 July 2009
Scan the full text
Cite this article
0
Views
0
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album
Related Articles
Preparation, characterization and radiolabelling of antigranulocyte monoclonal antibody
LABELING McAb 3H11 AND ITS Fab FRAGMENT WITH 211 At AND THEIR IMMUNOREACTIVITIES AND INJURY EFFECTS ON HUMAN GASTRIC CANCER CELLS
TUMOR UPTAKE AND THERAPEUTIC EFFECT OF ASTATINATED INTACT McAb 3H11 AND ITS Fab FRAGMENT FOR HUMAN GASTRIC CANCER XENOGRAFT IN NUDE MICE
Related Author
Jinming ZHANG
Fangping XUE
Xiangtong LIN
Zhaoxiang GU
Jiannan Jin
Zhiwei Dong
Wenhui Wan
Fangyuan Wang
Related Institution
Huashan hospital, Shanghai Medical University
Institute of Nuclear Science and Technology, Sichuan Union University
Institute of Cancer Research, West China University of Medical Sciences
Beijing Institute for Cancer Research
Institute of Nucl Sci and Technol, Sichuan Union University
0